# The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

> **NCT01311037** · — · UNKNOWN · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 2 (estimated)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **OTHER:** GnRh Analogue and Aromatase Inhibitor

## Key facts

- **NCT ID:** NCT01311037
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2011-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311037, "The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01311037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*